World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
16025
World Ranking
9590
National Ranking
731

Overview

Duncan M. Geddes is affiliated with Imperial College London in the United Kingdom. Their research contributions focus on respiratory disease management, as reflected in recent scholarly output.

The scientist has authored multiple papers published in the journal Medicine. These include:

  • The history of respiratory disease management, 2020, Medicine
  • The history of respiratory disease management, 2023, Medicine

Both papers address the broader topic of respiratory disease management, contributing to knowledge within this medical specialty.

Duncan M. Geddes's publications appear primarily in Medicine, indicating a targeted engagement with this particular venue and its readership.

Despite the limited number of publications, the citation counts indicate ongoing recognition within the relevant academic community.

Best Publications

  • Two-, six-, and 12-minute walking tests in respiratory disease

    R. J.A. Butland;J. Pang;E. R. Gross;A. A. Woodcock

  • Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

    Natasha J. Caplen;Eric W.F.W. Alton;Peter G. Mddleton;Julia R. Dorin

  • Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.

    E. W. F. W. Alton;M. Stern;R. Farley;A. Jaffe

  • Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

    E W Alton;P G Middleton;N J Caplen;S N Smith

  • Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

    Eric W F W Alton;David K Armstrong;Deborah Ashby;Katie J Bayfield

  • Effect of lung-volume-reduction surgery in patients with severe emphysema.

    Duncan Geddes;Michael Davies;Hiroshi Koyama;David Hansell

  • Bronchoscopic volume reduction with valve implants in patients with severe emphysema.

    Tudor P Toma;Nicholas S Hopkinson;James Hillier;David M Hansell

  • Cystic fibrosis in the mouse by targeted insertional mutagenesis.

    Julia R. Dorin;Paul Dickinson;Eric W. F. W. Alton;Stephen N. Smith

  • Effect of Bronchoscopic Lung Volume Reduction on Dynamic Hyperinflation and Exercise in Emphysema

    Nicholas S. Hopkinson;Tudor P. Toma;David M. Hansell;Peter Goldstraw

  • Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood Gases

    Ashley A. Woodcock;Elizabeth R. Gross;Andrew Gellert;Smita Shah

  • Efficient gene transfer to airway epithelium using recombinant Sendai virus

    Yoshikazu Yonemitsu;Christopher Kitson;Stefano Ferrari;Raymond Farley

  • Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis.

    Amanda L. Brennan;Khin M. Gyi;David M. Wood;Julie Johnson

  • Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

    Ranasinha C;Assoufi B;Shak S;Christiansen D

  • Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis.

    Stefano Ferrari;Duncan M Geddes;Eric W.F.W Alton

  • In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE

    N. J. Caplen;E. Kinrade;F. Sorgi;X. Gao

  • Increased Leukotriene B4 and Interleukin-6 in Exhaled Breath Condensate in Cystic Fibrosis

    Giovanna E. Carpagnano;Peter J. Barnes;Duncan M. Geddes;Margaret E. Hodson

  • Clinical importance of cystic fibrosis-related diabetes.

    Amanda L. Brennan;Duncan M. Geddes;Khin M. Gyi;Emma H. Baker

  • Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium

    P. G. Middleton;D. M. Geddes;E. W. F. W. Alton

  • Atelectasis and survival after bronchoscopic lung volume reduction for COPD

    NS Hopkinson;SV Kemp;TP Toma;DM Hansell

  • No added benefit from nebulized amiloride in patients with cystic fibrosis

    A. Graham;A. Hasani;E. W. F. W. Alton;G. P. Martin

Frequent Co-Authors

Eric W.F.W. Alton
Eric W.F.W. Alton National Institutes of Health
Uta Griesenbach
Uta Griesenbach National Institutes of Health
David J. Porteous
David J. Porteous University of Edinburgh
Stefano Ferrari
Stefano Ferrari Veneto Eye Bank Foundation
David M. Hansell
David M. Hansell National Institutes of Health
Natasha J. Caplen
Natasha J. Caplen National Institutes of Health
Andrew Bush
Andrew Bush Imperial College London
Ronald K. Scheule
Ronald K. Scheule Sanofi (United States)
Seng H. Cheng
Seng H. Cheng Pfizer (United States)
Leaf Huang
Leaf Huang University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Duncan M. Geddes

Trending Scientists